To explore possible tumor extrinsic and intrinsic factors by which RASD1 levels could potentially influence patient survival outcomes, we sought to compare immune cell infiltrates and gene set enrichments that were different between RASD1 high vs. low tumors. Here, RASD1 is linked to neoplasm.